Cargando…
Antiproliferative and apoptotic effects of xanthohumol in cholangiocarcinoma
Cholangiocarcinoma remains the second most prevalent hepatic neoplasm in the United States with a 5-year survival rate of less than 10%. Currently, no systemic therapy has demonstrated efficacy. Therefore, an urgent need for the identification of molecularly targeted compound(s) remains. The Notch s...
Autores principales: | Walden, Daniel, Kunnimalaiyaan, Selvi, Sokolowski, Kevin, Clark, T. Gamblin, Kunnimalaiyaan, Muthusamy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675694/ https://www.ncbi.nlm.nih.gov/pubmed/29152142 http://dx.doi.org/10.18632/oncotarget.21422 |
Ejemplares similares
-
Xanthohumol Inhibits Notch Signaling and Induces Apoptosis in Hepatocellular Carcinoma
por: Kunnimalaiyaan, Selvi, et al.
Publicado: (2015) -
Antiproliferative and apoptotic effect of LY2090314, a GSK-3 inhibitor, in neuroblastoma in vitro
por: Kunnimalaiyaan, Selvi, et al.
Publicado: (2018) -
Xanthohumol increases death receptor 5 expression and enhances apoptosis with the TNF-related apoptosis-inducing ligand in neuroblastoma cell lines
por: Engelsgjerd, Samuel, et al.
Publicado: (2019) -
Inhibition of the AKT pathway in cholangiocarcinoma by MK2206 reduces cellular viability via induction of apoptosis
por: Wilson, Jacob M, et al.
Publicado: (2015) -
Tumor Suppressor Role of Notch1 and Raf-1 Signaling in Medullary Thyroid Cancer Cells
por: Kunnimalaiyaan, Muthusamy, et al.
Publicado: (2007)